Literature DB >> 15257040

Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection.

Manfred G Krukemeyer1, Johannes Moeller, Lars Morawietz, Birgit Rudolph, Ulf Neumann, Tom Theruvath, Peter Neuhaus, Veit Krenn.   

Abstract

BACKGROUND: Although antibody mechanisms play a pathogenetic role in liver allograft rejection, no data exist on B lymphocytes, plasma cells, complement, and chemokines in rejected liver tissue.
METHODS: Liver biopsy specimens from 25 patients with acute allograft rejection (AR) (rejection activity index, RAI score: 1-9) were analyzed by immunohistochemistry (IH) and reverse transcriptase-polymerase chain reaction (RT-PCR) and compared with biopsy specimens taken prior to implantation (PI). The number of CD20 and CD138 cells was evaluated, and the presence and abundance of the chemokines macrophage inflammatory protein (MIP)-3alpha, CXCL9, CXCL10, CXCL11, CXCL12, and their receptors CCR-6, CXCR3, and CXCR4 were examined. Complement depositions were visualized by C4d IH.
RESULTS: The numbers of B lymphocytes (P=0.002) and plasma cells (P=0.022) were significantly higher in AR biopsy specimens compared with PI biopsy specimens. MIP-3alpha and CCR-6 cells were detected in the portal fields of all AR biopsy specimens. IH double staining revealed a colocalization of MIP-3alpha/CD20 cells; C4d deposits could be demonstrated along the portal capillaries. All examined chemokines and receptors could be detected in normal liver tissue and in AR biopsy specimens by RT-PCR and semiquantitative RT-PCR, demonstrating an overexpression of CXCL10 and -11.
CONCLUSIONS: The significant increase of B lymphocytes and plasma cells during acute rejection, together with the lack of a significant increase of proliferating cells, indicates that the migration of B lymphocytes and plasma cells-promoted by the expression of B-cell activating chemokines/receptors-plays a key role in acute liver rejection. The C4d deposits along the portal capillaries indicate a humorally mediated alloresponse caused by the accumulated B and plasma cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257040     DOI: 10.1097/01.tp.0000132324.14207.8b

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  15 in total

1.  Molecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipients.

Authors:  Ricardo Gehrau; Daniel Maluf; Kellie Archer; Richard Stravitz; Jihee Suh; Ngoc Le; Valeria Mas
Journal:  Mol Med       Date:  2011-04-20       Impact factor: 6.354

2.  Molecular case report: IgVH analysis in acute humoral and cellular liver allograft rejection suggests a selected accumulation of effector B cells and plasma cells.

Authors:  Johannes Moeller; Manfred G Krukemeyer; Lars Morawietz; Max Schmeding; Anja Dankof; Ulf Neumann; Veit Krenn; Claudia Berek
Journal:  Virchows Arch       Date:  2005-02-16       Impact factor: 4.064

Review 3.  Immune Cell Trafficking to the Liver.

Authors:  Sulemon Chaudhry; Jean Emond; Adam Griesemer
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

4.  Increased hematopoietic cells in the mertk-/- mouse peritoneal cavity: a result of augmented migration.

Authors:  Julie C Williams; Nikki J Wagner; H Shelton Earp; Barbara J Vilen; Glenn K Matsushima
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

5.  Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay.

Authors:  Omar Massoud; Julie Heimbach; Kimberly Viker; Anuradha Krishnan; John Poterucha; William Sanchez; Kymberly Watt; Russell Wiesner; Michael Charlton
Journal:  Liver Transpl       Date:  2011-06       Impact factor: 5.799

6.  The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.

Authors:  A I Musat; R M Agni; P Y Wai; J D Pirsch; D F Lorentzen; A Powell; G E Leverson; J M Bellingham; L A Fernandez; D P Foley; J D Mezrich; A M D'Alessandro; M R Lucey
Journal:  Am J Transplant       Date:  2011-03       Impact factor: 8.086

7.  Quantification of C4d deposition and hepatitis C virus RNA in tissue in cases of graft rejection and hepatitis C recurrence after liver transplantation.

Authors:  Alice Tung Wan Song; Evandro Sobroza de Mello; Venâncio Avancini Ferreira Alves; Norma de Paula Cavalheiro; Carlos Eduardo Melo; Patricia Rodrigues Bonazzi; Fatima Mitiko Tengan; Maristela Pinheiro Freire; Antonio Alci Barone; Luiz Augusto Carneiro D'Albuquerque; Edson Abdala
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-02-13       Impact factor: 2.743

Review 8.  ABO-compatible liver allograft antibody-mediated rejection: an update.

Authors:  Anthony J Demetris; Adriana Zeevi; Jacqueline G O'Leary
Journal:  Curr Opin Organ Transplant       Date:  2015-06       Impact factor: 2.640

9.  Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection.

Authors:  Anja Dankof; Maximilian Schmeding; Lars Morawietz; Raphaela Günther; Manfred G Krukemeyer; Birgit Rudolph; Martin Koch; Veit Krenn; Ulf Neumann
Journal:  Virchows Arch       Date:  2005-06-10       Impact factor: 4.064

Review 10.  Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.

Authors:  Antonio Cuadrado; David San Segundo; Marcos López-Hoyos; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.